Skip to content

Study on the effects of meal frequency on glucose metabolism in subjects with normal glucose tolerance and impaired fasting glucose (g2010008)

Study on the effects of meal frequency on glucose metabolism in subjects with normal glucose tolerance and impaired fasting glucose (g2010008) - Effects of meal frequency on glucose metabolism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036661
Enrollment
20
Registered
2019-05-07
Start date
2011-01-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Participants intake 3 meals per day for 3-day, after wash out for 2 weeks, intake 9 meals per day for 3-day Participants intake 9 meals per day for 3-day, after wash out for 2 weeks, intake 3 meals pe

Sponsors

DRC Corporation, Ltd. Product Testing Department
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Subjects aged 30 to 59 years old. (2) For impaired glucose tolerance, fasting blood glucose levels are <= 100 mg/dL and HbA1c levels are <=5.8%, for impaired glucose tolerance, fasting blood glucose level are between 110 mg/dL to 125 mg/dL and HbA1c levels are between 5.8%-6.4%. (3) Subjects who can received study explanation and agree to participate in this study with written consent.

Exclusion criteria

Exclusion criteria: (1) Subjects who have serious cardio-vascular, hepatic, renal, respiratory, endocrine, metabolic, or gastrointestinal diseases, or who have a medical history of these diseases. (2) Subjects who take medicine of hyperlipidemia or diabetes. (3) Subjects who have food allergy. (4) Subjects who is now included in other clinical studies, or who will participate in other clinical studies. (5) Subjects who experienced unpleasant feeling during blood collection. (6) Smoker (7) Heavy drinker (Over 30g alcohol per day) (8) Subjects who considered unsuitable for this study by the study investigators.

Design outcomes

Primary

MeasureTime frame
Glucose metabolism after intervention (blood glucose and insulin levels)

Secondary

MeasureTime frame
Daily variation in blood glucose using CGMs, and GLP-1, GLP, cortisol, keton-body after intervention.

Countries

Japan

Contacts

Public ContactMasafumi Takano

DRC Co., Ltd Product Testing Department

m.takano@drc-web.co.jp06-6882-1130

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026